Personalized neuro-regenerative recovery in Istanbul
Stem cell therapy for stroke recovery in Istanbul
Once acute hospital care is complete and you are medically stable, Uzm. Dr. Cihan Bolat and our medical team evaluate your brain imaging and recovery history to design a tailored Wharton's jelly MSC and exosome protocol supporting neuroplasticity and the post-stroke neural microenvironment.
Understanding post-stroke recovery and our regenerative approach
After an ischemic or hemorrhagic stroke has been stabilized by emergency hospital care, the brain enters a prolonged recovery phase centered around the peri-infarct zone — the living ring of brain tissue surrounding the stroke core. Although neurons and glial cells in this border zone survive the initial vascular event, they often remain trapped in a state of chronic microglial neuroinflammation, impaired capillary blood flow, blood-brain barrier disruption, and reduced neurotrophic support, which limits the brain's ability to rewire motor, speech, and cognitive pathways.
Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) and WJ-MSC-derived exosomes are investigated for their ability to rejuvenate this peri-infarct microenvironment and amplify neuroplasticity. Inside the body, WJ-MSCs and their nanoscale exosomes release a coordinated cascade of neurotrophic and angiogenic growth factors — including brain-derived neurotrophic factor (BDNF), vascular endothelial growth factor (VEGF), nerve growth factor (NGF), hepatocyte growth factor (HGF), and insulin-like growth factor-1 (IGF-1) — alongside regenerative microRNAs. These biological signals calm neurotoxic M1 microglia into reparative M2 states, stimulate microvascular angiogenesis to improve local oxygen and nutrient perfusion, help oligodendrocyte precursors remyelinate surviving white-matter tracts, and encourage surviving neurons to sprout new dendritic spines and synaptic connections.
At our clinic in Istanbul, led by Uzm. Dr. Cihan Bolat, our medical team evaluates your hospital discharge summaries, brain MRI or CT scans, vascular history, and current medications to design an individualized protocol once you are medically stable for travel. By combining intrathecal WJ-MSC administration, intravenous WJ-MSC and exosome infusions, and intranasal exosomes alongside your ongoing physical, occupational, and speech rehabilitation, our protocols aim to support limb mobility, hand dexterity, speech fluency, cognitive stamina, and greater daily independence.
Reviewed by: Uzm. Dr. Cihan Bolat · Reviewed · Re-review due
What happens inside the body
What happens inside the brain after a stroke — and how biologics support recovery
Four biological processes shape the brain's microenvironment after a cerebrovascular injury. Understanding each process shows how Wharton's jelly MSCs and exosomes help protect and remodel surviving neural networks.
Therapeutic objectives of our protocol
Our regenerative protocols are provided once you are medically stable for travel, supporting biological recovery pathways while you continue secondary stroke-prevention medicines and rehabilitation with your local physicians.
Modulating persistent post-ischemic neuroinflammation and microglial activation in the peri-infarct zone
Supporting microvascular endothelial signaling, angiogenesis, and blood-brain barrier integrity
Supplying paracrine neurotrophic factors and exosomal microRNAs that encourage synaptic and axonal plasticity
Regulating systemic peripheral-to-central inflammatory pathways after cerebrovascular injury
Supporting motor, speech, cognitive, and daily functional recovery goals alongside your ongoing rehabilitation
01
Post-ischemic neuroinflammation & microglial activation in the peri-infarct zone
Long after the acute stroke event has passed, activated microglia and infiltrating immune cells around the infarct border continue releasing pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6) and reactive oxygen species that suppress neuronal excitability and hinder recovery.
Intrathecal and intravenous WJ-MSCs counter this chronic inflammatory state by secreting IL-10, TGF-beta, and TSG-6, shifting microglia from destructive M1 activity toward reparative M2 phenotypes that clear cellular debris and support tissue healing in the peri-infarct zone.
Cerebrovascular injury damages small capillary networks and weakens endothelial tight junctions, leaving surviving peri-lesional brain tissue with compromised blood flow, reduced oxygen delivery, and impaired metabolic waste clearance.
Wharton's jelly MSCs and their exosomes release potent pro-angiogenic signals — including VEGF, angiopoietin-1, and endothelial-repair microRNAs — that stimulate new capillary sprouting, stabilize the blood-brain barrier, and restore healthier neurovascular perfusion to recovering brain regions.
03
Synaptic & axonal remodeling challenges in surviving neural networks
Recovering lost motor, speech, or sensory function requires surviving neurons to extend new axonal branches, form fresh synapses, and remyelinate subcortical white-matter fibers — a process that stalls when local neurotrophic factors are depleted.
WJ-MSCs and nanoscale exosomes deliver concentrated BDNF, NGF, GDNF, and neurogenic microRNAs directly to neurons and oligodendrocyte precursors, promoting dendritic spine formation, axonal remodeling, and white-matter myelin support that pair synergistically with task-specific rehabilitation.
04
Systemic inflammatory cross-talk after cerebrovascular injury
A stroke triggers a body-wide immune and neurohormonal stress response in the spleen and peripheral circulation, feeding chronic inflammatory signals back across the blood-brain barrier and contributing to post-stroke fatigue.
Systemic intravenous infusions of WJ-MSCs and exosomes rebalance peripheral immune cell populations, expand regulatory T cells (Tregs), and lower systemic vascular inflammation, creating a healthier whole-body internal environment for neurological recovery.
Why regenerative medicine is investigated
Scientific rationale for Wharton's jelly MSCs and exosomes
Biological rationale
Unlocking neuroplasticity and vascular repair in the peri-infarct zone
Meaningful recovery after a stroke depends on neuroplasticity — the ability of surviving brain regions and intact neural tracts to form new synapses and take over functions previously handled by damaged tissue. However, persistent post-ischemic inflammation, astroglial scar signaling, and poor microvascular perfusion in the peri-infarct zone frequently stall this natural rewiring process. Regenerative medicine focuses on resolving chronic peri-lesional inflammation, rebuilding capillary microcirculation, and supplying concentrated neurotrophic signals so that surviving neural networks can reorganize more effectively in response to rehabilitation.
WJ-MSCs & exosomes
Synergistic angiogenic, neurotrophic, and vesicular repair signaling
Wharton's jelly-derived MSCs and their purified exosomes work together to address both the vascular and neural dimensions of post-stroke recovery. Live WJ-MSCs modulate systemic and central immune responses, shifting pro-inflammatory macrophages and microglia toward tissue-reparative phenotypes while secreting VEGF, BDNF, GDNF, and HGF. Simultaneously, nanoscale WJ-MSC exosomes cross the blood-brain barrier and deliver specific regulatory microRNAs (such as miR-133b and miR-17-92 cluster signals studied in neural remodeling) directly into peri-infarct neurons, oligodendrocytes, and cerebral endothelial cells to promote axonal sprouting, synaptic plasticity, and microvascular integrity.
Individualized protocol
Planned around your stroke subtype, imaging, and anticoagulant safety
Post-stroke recovery needs differ markedly depending on whether the stroke was ischemic or hemorrhagic, which cerebral territory was affected, and which blood-thinning or blood-pressure medications you take. Our medical team carefully reviews your brain MRI or CT scans, vascular workup, coagulation profile, and rehabilitation notes before proposing a protocol. We customize your Wharton's jelly MSC count, exosome concentration, and the safe timing of intrathecal, intravenous, and intranasal administration routes, explaining every clinical detail and cost before you travel to Istanbul.
Our treatment approach & administration routes
Our four-part neurological protocol for post-stroke recovery
When clinically appropriate after reviewing your neurological and vascular records, our medical team combines four complementary administration pathways using GMP-certified Wharton's jelly MSCs and exosomes.
01
Intrathecal WJ-MSC Administration
Delivered via lumbar puncture with or without sedation depending on clinical circumstances, intrathecal administration places fresh, GMP-certified Wharton's jelly-derived MSCs directly into the cerebrospinal fluid. Bypassing the blood-brain barrier, the cells circulate through the CSF pathways to bathe the central nervous system in BDNF, VEGF, NGF, HGF, and anti-inflammatory cytokines that support peri-infarct neuroplasticity and white-matter repair.
Role in your protocolCarefully coordinated around your antiplatelet or anticoagulant medication schedule after thorough review by our medical team.
02
Intravenous WJ-MSC Administration
Systemic intravenous infusion of Wharton's jelly-derived MSCs regulates peripheral immune responses, shifts inflammatory monocytes toward reparative M2 macrophages, and releases circulating angiogenic and trophic factors that support cerebral and systemic vascular endothelium.
Role in your protocolProvides systemic immunomodulation and neurovascular paracrine support without requiring invasive arterial catheterization or cranial surgery.
03
Intravenous WJ-MSC Exosome Administration
Wharton's jelly MSC-derived exosomes are nanoscale extracellular vesicles carrying growth factors, neuroprotective proteins, and regulatory microRNAs. Infused intravenously, they traverse the blood-brain barrier to reach peri-infarct neurons, astrocytes, oligodendrocytes, and microvessels, promoting intercellular communication and synaptic remodeling.
Role in your protocolAdministered intravenously to deliver concentrated vesicular repair signals across both systemic vascular and central neural pathways.
04
Intranasal Exosome Administration
Non-invasive intranasal delivery applies concentrated WJ-MSC-derived exosomes to the upper nasal cavity to engage olfactory and trigeminal nose-to-brain neural pathways, providing a gentle, needle-free route for delivering neurotrophic and anti-inflammatory vesicles toward the brain.
Role in your protocolProvides a non-invasive central adjunct; we note transparently that the exact proportion of intranasally administered exosomes reaching specific human brain regions remains under study.
What we aim to achieve
How biological repair signaling connects to your recovery milestones
Our medical team records your baseline motor, speech, and functional status before treatment in Istanbul and follows your progress at 1, 3, and 6 months alongside your local rehabilitation specialists.
01
Upper & lower limb motor control and spasticity comfort
By delivering BDNF, NGF, and exosomal remodeling signals to the peri-infarct motor cortex and descending corticospinal tracts, the protocol aims to support synaptic rewiring and calmer muscle tone during physical therapy. We document baseline limb strength, hand grasp and finger dexterity, gait balance, and spasticity to track motor progress over time.
02
Speech fluency, swallowing & cognitive stamina
Supporting microvascular perfusion and calming chronic glial inflammation in language and executive networks aims to assist patients working to overcome post-stroke aphasia, dysarthria, or mental fatigue. During follow-up, we track communication clarity, word retrieval, attention span, and cognitive endurance.
03
Daily independence & functional participation
As neuroplasticity and systemic energy are supported, patients work with their local occupational and physical therapists to translate biological signaling into everyday skills. We review practical milestones such as independent transfers, dressing, walking endurance, and confidence in daily life.
04
Procedure safety & coordinated 1, 3, and 6-month follow-up
We monitor your blood pressure, neurological status, and comfort throughout your stay in Istanbul while coordinating safely around your secondary stroke-prevention medicines. Structured remote reviews at 1, 3, and 6 months track your recovery trajectory alongside your home physicians.
How treatment is personalized
How our medical team evaluates your stroke recovery case
When you contact us, we request your stroke discharge reports, brain imaging, and current medication list. Uzm. Dr. Cihan Bolat and our medical team evaluate your medical stability and recovery stage, design an individualized WJ-MSC and exosome protocol where appropriate, and explain the administration routes, therapeutic objectives, and costs before you travel.
Medical history & reports we request
Hospital neurology summary detailing stroke type (ischemic or hemorrhagic), date of onset, and initial treatment
Recent brain MRI or CT scans and vascular imaging reports
Complete current medication list, especially antiplatelet or anticoagulant blood thinners and blood-pressure medicines
Recent physical, occupational, or speech rehabilitation notes describing current functional goals
Recent routine blood tests, cardiac stability summary, and general medical history
Clinical suitability & timing checks
Any new, sudden, or worsening stroke or transient ischemic attack (TIA) symptoms — seek emergency hospital care immediately
Uncontrolled blood pressure, unstable cardiac arrhythmias, recent deep vein thrombosis, or active systemic infection
Unreviewed anticoagulant or antiplatelet therapy prior to scheduling an intrathecal lumbar procedure
Early post-stroke medical instability where the treating neurologist has not yet cleared the patient for travel
What the patient journey looks like
From your first inquiry to individualized treatment in Istanbul
Reach out regarding your condition and share your medical history, diagnosis, imaging, and relevant lab reports via our secure form or WhatsApp.
02
Medical team evaluation & protocol design
Our medical team evaluates your records and, where clinically appropriate, develops an individualized Wharton's jelly MSC and exosome protocol.
03
Transparent explanation of protocol & costs
We explain the proposed treatment, specific biologics, administration routes, intended therapeutic objectives, stay timeline, and itemized costs.
04
Arrange treatment in Istanbul & follow-up
Review your individualized proposal, schedule your visit to Istanbul with private airport and clinic transfers, and continue with structured 1, 3, and 6-month follow-up.
2026 cost & protocol planning
Stroke recovery treatment cost in Istanbul
After evaluating your medical records, we provide a transparent, itemized treatment plan outlining the recommended Wharton's jelly MSC and exosome dosages, intrathecal, intravenous, and intranasal administration routes, clinical monitoring, and airport and hotel support in Istanbul.
Our 2026 neurological program band starts from $9,000–$25,000 depending on cell dosage, exosome concentration, and selected administration routes, confirmed after your free medical evaluation.
Individualized Wharton's jelly MSC count and MSC-derived exosome dosage prescribed for your recovery phase
Combination of intrathecal (with or without sedation), intravenous, and intranasal administration pathways
Number of administration days, hospital procedure setting, and clinical monitoring requirements
GMP laboratory release certificates, accessible airport/hotel transfers, and 1, 3, and 6-month follow-up
Which combination of intrathecal WJ-MSCs, intravenous WJ-MSCs, and exosomes fits my stroke subtype and stage of recovery?
02
How my antiplatelet or anticoagulant blood thinners are safely coordinated with the proposed administration routes.
03
What biological and functional recovery goals our protocol aims to support alongside my ongoing rehabilitation.
04
My exact itemized treatment quote, travel logistics, and expected length of stay in Istanbul.
Evidence & important considerations
Clinical evidence and important scientific context
Clinical trials in stroke have investigated both acute intravenous progenitor infusions within hours of stroke onset and subacute-to-chronic regenerative protocols. We present key published studies transparently so patients understand how study timing, cell sources, and routes differ, and why regenerative therapy is offered as supportive biological care rather than a guaranteed cure.
Demonstrated acceptable infusion safety in acute ischemic stroke; while the 90-day primary global endpoint was neutral, exploratory analyses noted signals in earlier administration windows and longer-term follow-up.
Limitation
Tested an acute hospital intervention within 24–48 hours of stroke onset, distinct from elective subacute or chronic Wharton's jelly MSC and exosome recovery protocols.
Randomized double-blind placebo-controlled trial, 206 adults with acute ischemic stroke
Finding
Confirmed a comparable safety profile to placebo in acute ischemic stroke, though the primary composite endpoint at day 90 was not met.
Limitation
Highlights that a single acute intravenous cell dose does not guarantee functional recovery, reinforcing the importance of realistic expectations and ongoing rehabilitation.
Allogeneic human neural stem-cell line implanted into the putamen
Study design
Prospective open-label single-arm study, 23 people in subacute-chronic recovery
Finding
Evaluated neurosurgical intracerebral implantation of a neural cell line in chronic stroke, observing feasibility and exploratory upper-limb changes in a subset of patients.
Limitation
Involved invasive neurosurgical brain implantation rather than our clinic's non-surgical intrathecal, intravenous, and intranasal WJ-MSC and exosome protocols.
Patients can be evaluated once acute hospital treatment is complete, cardiovascular and neurological status is stable, and their local physician confirms they are safe for travel. Share your discharge summary and imaging for a free review.
Request Free Medical Evaluation
Begin a personalized treatment conversation with our medical team.
Share your case in confidence. Our international coordinators review every enquiry and respond within 24 hours, in your language.
